` EBOSY (EBOS Group Ltd) vs S&P 500 Comparison - Alpha Spread

E
EBOSY
vs
S&P 500

Over the past 12 months, EBOSY has underperformed S&P 500, delivering a return of -15% compared to the S&P 500's +12% growth.

Stocks Performance
EBOSY vs S&P 500

Loading
EBOSY
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
EBOSY vs S&P 500

Loading
EBOSY
S&P 500
Difference
www.alphaspread.com

Performance By Year
EBOSY vs S&P 500

Loading
EBOSY
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
EBOS Group Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

EBOS Group Ltd
Glance View

Market Cap
7.1B USD
Industry
Health Care

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is a marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. The company sources and supplies a range of surgical, medical, and pharmaceutical products. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics and Clinect.

EBOSY Intrinsic Value
36.1 USD
Undervaluation 3%
Intrinsic Value
Price
E
Back to Top